Catherine Scholz

Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study

Asit Parikh, Timothy Leach, Tim Wyant et al. · Inflammatory Bowel Diseases · 2011 · 207 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>Mutations

Alan L. Ho, Irene Braña, Robert I. Haddad et al. · Journal of Clinical Oncology · 2021 · 196 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Leukemia · 2021 · 178 citations · Full text

Medicine, Hematology, Pharmacology +14

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Lia Gore, Mace L. Rothenberg, Cindy L. O’Bryant et al. · Clinical Cancer Research · 2008 · 173 citations · Full text

Medicine, Oncology, Pharmacology +12

A phase I surrogate endpoint study of SU6668 in patients with solid tumors

Henry Q. Xiong, Roy S. Herbst, Silvana C. Faria et al. · Investigational New Drugs · 2004 · 85 citations

Medicine, Oncology, Cancer Pharmacology +9